CytoMed Therapeutics Receives Nasdaq Noncompliance Notice

CytoMed Therapeutics Limited (NASDAQ: GDTC) received a notice from Nasdaq on October 6, 2026, indicating that its ordinary shares have been trading below the minimum bid price of $1.00 for the past 30 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2). The notice does not currently affect the listing or trading of the company's shares on Nasdaq.